Abramson Cancer Center at Penn Medicine — Clinical Trial Pipeline

Abramson Cancer Center at Penn Medicine has 8 registered trials in the index.

Trials (8)

• LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey N/A · Abramson Cancer Center at Penn Medicine
• Comparing Numbing Techniques in Mohs Micrographic Surgery N/A · Abramson Cancer Center at Penn Medicine
• Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain N/A · Abramson Cancer Center at Penn Medicine
• CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer Early Phase 1 · Abramson Cancer Center at Penn Medicine
• Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant N/A · Abramson Cancer Center at Penn Medicine
• Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC) Early Phase 1 · Abramson Cancer Center at Penn Medicine
• A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer N/A · Abramson Cancer Center at Penn Medicine
• Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab Phase 1 · Abramson Cancer Center at Penn Medicine

Related landscapes

• Breast Cancer
• Cancer Patient
• Skin Cancer Face
• Skin Cancer Scalp
• Recurrent Breast Cancer

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.